Cargando…

Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union

Novel microbes are either newly isolated genera and species from natural sources or bacterial strains derived from existing bacteria. Novel microbes are gaining increasing attention for the general aims to preserve and modify foods and to modulate gut microbiota. The use of novel microbes to improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Brodmann, Theodor, Endo, Akihito, Gueimonde, Miguel, Vinderola, Gabriel, Kneifel, Wolfgang, de Vos, Willem M., Salminen, Seppo, Gómez-Gallego, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601064/
https://www.ncbi.nlm.nih.gov/pubmed/28955311
http://dx.doi.org/10.3389/fmicb.2017.01725
_version_ 1783264320365264896
author Brodmann, Theodor
Endo, Akihito
Gueimonde, Miguel
Vinderola, Gabriel
Kneifel, Wolfgang
de Vos, Willem M.
Salminen, Seppo
Gómez-Gallego, Carlos
author_facet Brodmann, Theodor
Endo, Akihito
Gueimonde, Miguel
Vinderola, Gabriel
Kneifel, Wolfgang
de Vos, Willem M.
Salminen, Seppo
Gómez-Gallego, Carlos
author_sort Brodmann, Theodor
collection PubMed
description Novel microbes are either newly isolated genera and species from natural sources or bacterial strains derived from existing bacteria. Novel microbes are gaining increasing attention for the general aims to preserve and modify foods and to modulate gut microbiota. The use of novel microbes to improve health outcomes is of particular interest because growing evidence points to the importance of gut microbiota in human health. As well, some recently isolated microorganisms have promise for use as probiotics, although in-depth assessment of their safety is necessary. Recent examples of microorganisms calling for more detailed evaluation include Bacteroides xylanisolvens, Akkermansia muciniphila, fructophilic lactic acid bacteria (FLAB), and Faecalibacterium prausnitzii. This paper discusses each candidate's safety evaluation for novel food or novel food ingredient approval according to European Union (EU) regulations. The factors evaluated include their beneficial properties, antibiotic resistance profiling, history of safe use (if available), publication of the genomic sequence, toxicological studies in agreement with novel food regulations, and the qualified presumptions of safety. Sufficient evidences have made possible to support and authorize the use of heat-inactivated B. xylanisolvens in the European Union. In the case of A. muciniphila, the discussion focuses on earlier safety studies and the strain's suitability. FLAB are also subjected to standard safety assessments, which, along with their proximity to lactic acid bacteria generally considered to be safe, may lead to novel food authorization in the future. Further research with F. prausnitzii will increase knowledge about its safety and probiotic properties and may lead to its future use as novel food. Upcoming changes in EUU Regulation 2015/2283 on novel food will facilitate the authorization of future novel products and might increase the presence of novel microbes in the food market.
format Online
Article
Text
id pubmed-5601064
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56010642017-09-27 Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union Brodmann, Theodor Endo, Akihito Gueimonde, Miguel Vinderola, Gabriel Kneifel, Wolfgang de Vos, Willem M. Salminen, Seppo Gómez-Gallego, Carlos Front Microbiol Microbiology Novel microbes are either newly isolated genera and species from natural sources or bacterial strains derived from existing bacteria. Novel microbes are gaining increasing attention for the general aims to preserve and modify foods and to modulate gut microbiota. The use of novel microbes to improve health outcomes is of particular interest because growing evidence points to the importance of gut microbiota in human health. As well, some recently isolated microorganisms have promise for use as probiotics, although in-depth assessment of their safety is necessary. Recent examples of microorganisms calling for more detailed evaluation include Bacteroides xylanisolvens, Akkermansia muciniphila, fructophilic lactic acid bacteria (FLAB), and Faecalibacterium prausnitzii. This paper discusses each candidate's safety evaluation for novel food or novel food ingredient approval according to European Union (EU) regulations. The factors evaluated include their beneficial properties, antibiotic resistance profiling, history of safe use (if available), publication of the genomic sequence, toxicological studies in agreement with novel food regulations, and the qualified presumptions of safety. Sufficient evidences have made possible to support and authorize the use of heat-inactivated B. xylanisolvens in the European Union. In the case of A. muciniphila, the discussion focuses on earlier safety studies and the strain's suitability. FLAB are also subjected to standard safety assessments, which, along with their proximity to lactic acid bacteria generally considered to be safe, may lead to novel food authorization in the future. Further research with F. prausnitzii will increase knowledge about its safety and probiotic properties and may lead to its future use as novel food. Upcoming changes in EUU Regulation 2015/2283 on novel food will facilitate the authorization of future novel products and might increase the presence of novel microbes in the food market. Frontiers Media S.A. 2017-09-12 /pmc/articles/PMC5601064/ /pubmed/28955311 http://dx.doi.org/10.3389/fmicb.2017.01725 Text en Copyright © 2017 Brodmann, Endo, Gueimonde, Vinderola, Kneifel, de Vos, Salminen and Gómez-Gallego. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Brodmann, Theodor
Endo, Akihito
Gueimonde, Miguel
Vinderola, Gabriel
Kneifel, Wolfgang
de Vos, Willem M.
Salminen, Seppo
Gómez-Gallego, Carlos
Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union
title Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union
title_full Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union
title_fullStr Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union
title_full_unstemmed Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union
title_short Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union
title_sort safety of novel microbes for human consumption: practical examples of assessment in the european union
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601064/
https://www.ncbi.nlm.nih.gov/pubmed/28955311
http://dx.doi.org/10.3389/fmicb.2017.01725
work_keys_str_mv AT brodmanntheodor safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion
AT endoakihito safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion
AT gueimondemiguel safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion
AT vinderolagabriel safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion
AT kneifelwolfgang safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion
AT devoswillemm safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion
AT salminenseppo safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion
AT gomezgallegocarlos safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion